Federal spending on medical research produces results and the National Institutes of Health periodically seeks to license patents on new discoveries and novel medical research techniques. Today, NIH issued a notice of an exclusive license on cancer targeting compounds and a separate request seeking to license a variety of techniques for HIV research and x-ray imaging, plus a new surgical tool for eye surgery.
Many developing technologies and techniques stem from research funding at NIH or through federal grants. Disseminating the fruits of federally funded research is governed by a law enacted in 1980, which allows for licensing of federal patents to industry. The law (view Congressional Research Service description) gives the title to inventions made with government support to small business, universities or other non-profit organizations and is credited with forging a vibrant biotechnology industry. Federal researchers retain the right to use the new innovations and the licensees are responsible for the often-arduous process of perfecting and developing the new technology.
Earlier this year, (@CQHealthTweet) HealthBeat’s Kerry Young’s monitored the various licensing missives from NIH and reported on the licensing of a technique that uses a rabies virus to develop a vaccine against the Ebola virus.